Patient Voice, • 9/19/25 Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Previous Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Next Leveraging Patient Advocacy To Scale Rare Disease Trials You Might Also Like What Matters to Payers: Conversations You Should Start During Phase 2 Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials
Patient Voice, • 9/19/25 Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Previous Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Next Leveraging Patient Advocacy To Scale Rare Disease Trials You Might Also Like What Matters to Payers: Conversations You Should Start During Phase 2 Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials
